{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:00:56Z","timestamp":1794409256989,"version":"4.9.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Vaccines targeting feline parvovirus (FPV), feline calicivirus (FCV), and feline herpesvirus type 1 (FHV-1) are considered core vaccines and are widely recommended for feline immunoprophylaxis. Currently, trivalent feline vaccines used in clinical settings are primarily based on inactivated or modified live attenuated formulations. Among these pathogens, FHV-1 has demonstrated notable potential as a viral vector due to its large genome and immunogenic profile, making it an attractive platform for multivalent vaccine development. In this study, we developed a novel trivalent live attenuated vaccine candidate by engineering FHV-1 as a viral vector to co-express immunogenic proteins from FPV and FCV. Using homologous recombination and CRISPR\/Cas9-mediated genome editing, we constructed the recombinant strain FHV \u0394gI\/gE\/TK-FCV VP1-FPV VP2, which expresses FCV VP1 and FPV VP2. Expression of these proteins was confirmed by Western blot and immunofluorescence assay (IFA), and the recombinant virus remained genetically stable during\n                    <jats:italic>in vitro<\/jats:italic>\n                    passaging. Immunization with this construct induced robust virus-neutralizing antibody responses and conferred protective immunity against both FHV-1 and FPV. These findings underscore the feasibility of using FHV-1 as a multivalent viral vector and provide a promising foundation for next-generation feline vaccines.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1636514","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:40Z","timestamp":1759401220000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["A novel feline herpesvirus vector subunit FCV VP1 and FPV VP2 vaccine protects cats against FHV-1 and FPV challenge and induces serum neutralizing antibody responses against FCV"],"prefix":"10.3389","volume":"16","author":[{"given":"Aoxing","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunchun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.11.073","article-title":"Complete protection of cats against feline panleukopenia virus challenge by a recombinant canine adenovirus type 2 expressing VP2 from FPV","volume":"26","author":"Yang","year":"2008","journal-title":"Vaccine"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.1999.214.01.67","article-title":"Outbreak of fatal salmonellosis in cats following use of a high-titer modified-live panleukopenia virus vaccine","volume":"214","author":"Foley","year":"1999","journal-title":"J Am Veterinary Med Assoc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X11432240","article-title":"Feline panleukopenia virus, feline herpesvirus-1 and feline calicivirus antibody responses in seronegative specific pathogen-free kittens after parenteral administration of an inactivated FVRCP vaccine or a modified live FVRCP vaccine","volume":"14","author":"Lappin","year":"2012","journal-title":"J Feline Med Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cvsm.2019.02.006","article-title":"Feline Panleukopenia: A re-emergent disease","volume":"49","author":"Barrs","year":"2019","journal-title":"Veterinary Clinics North A Small Anim Pract"},{"key":"B5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1006\/viro.1993.1288","article-title":"Structure, sequence, and function correlations among parvoviruses","volume":"194","author":"Chapman","year":"1993","journal-title":"Virology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2017.05.017","article-title":"Molecular characterization of feline panleukopenia virus isolated from mink and its pathogenesis in mink","volume":"205","author":"Fei-Fei","year":"2017","journal-title":"Veterinary Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12917-020-02422-3","article-title":"Study of the immunogenicity of the VP2 protein of canine parvovirus produced using an improved Baculovirus expression system","volume":"16","author":"Chang","year":"2020","journal-title":"BMC Vet Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"109978","DOI":"10.1016\/j.vetmic.2023.109978","article-title":"A potential dual protection vaccine: Recombinant feline herpesvirus-1 expressing feline parvovirus VP2 antigen","volume":"290","author":"Yang","year":"2024","journal-title":"Vet Microbiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.64.215","article-title":"An etiological investigation of domestic cats with conjunctivitis and upper respiratory tract disease in Japan","volume":"64","author":"Cai","year":"2002","journal-title":"J Veterinary Med Sci"},{"key":"B10","article-title":"Etiological investigation of multiple respiratory infections in cats","volume":"30","author":"Di Martino","year":"2007","journal-title":"New Microbiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2015.08.001","article-title":"Detection of feline upper respiratory tract disease pathogens using a commercially available real-time PCR test","volume":"206","author":"Litster","year":"2015","journal-title":"Veterinary J (London England: 1997)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S1098-612X(03)00008-1","article-title":"An epizootic of highly virulent feline calicivirus disease in a hospital setting in New England","volume":"5","author":"Schorr-Evans","year":"2003","journal-title":"J Feline Med Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1051\/vetres:2006056","article-title":"Feline calicivirus","volume":"38","author":"Radford","year":"2007","journal-title":"Veterinary Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/v14050937","article-title":"Calicivirus infection in cats","volume":"14","author":"Hofmann-Lehmann","year":"2022","journal-title":"Viruses"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.10.8496-8502.1999","article-title":"The capsid gene of feline calicivirus contains linear B-cell epitopes in both variable and conserved regions","volume":"73","author":"Radford","year":"1999","journal-title":"J Virol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2006.10.021","article-title":"Assembly of feline calicivirus-like particle and its immunogenicity","volume":"120","author":"Di Martino","year":"2007","journal-title":"Veterinary Microbiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-97-23783","article-title":"Isolation of a feline virus associated with intranuclear inclusion bodies","volume":"97","author":"Crandell","year":"1958","journal-title":"Proc Soc For Exp Biol Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1051\/vetres:2006063","article-title":"Feline herpesvirus","volume":"38","author":"Gaskell","year":"2007","journal-title":"Veterinary Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-008-0278-4","article-title":"The order herpesvirales","volume":"154","author":"Davison","year":"2009","journal-title":"Arch Virol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/v13112307","article-title":"Full viral genome sequencing and phylogenomic analysis of feline herpesvirus type 1 (FHV-1) in cheetahs ()","volume":"13","author":"Marino","year":"2021","journal-title":"Viruses"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfms.2005.12.001","article-title":"Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1","volume":"8","author":"Lappin","year":"2006","journal-title":"J Feline Med Surg"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1111\/jsap.2_12431","article-title":"WSAVA Guidelines for the vaccination of dogs and cats","volume":"57","author":"Day","year":"2016","journal-title":"J Small Anim Pract"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/v14040663","article-title":"Emerging respiratory viruses of cats","volume":"14","author":"Palombieri","year":"2022","journal-title":"Viruses"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/v14081602","article-title":"Vaccination and antibody testing in cats","volume":"14","author":"Egberink","year":"2022","journal-title":"Viruses"},{"key":"B25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12985-023-02053-8","article-title":"Pathogenicity and immunogenicity of gI\/gE\/TK-gene-deleted Felid herpesvirus 1 variants in cats","volume":"20","author":"Tang","year":"2023","journal-title":"Virol J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"126468","DOI":"10.1016\/j.vaccine.2024.126468","article-title":"The recombinant feline herpesvirus 1 expressing feline Calicivirus VP1 protein is safe and effective in cats","volume":"42","author":"Tang","year":"2024","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2018.08.029","article-title":"Isolation and molecular characterization of a virulent systemic feline calicivirus isolated in China","volume":"65","author":"Guo","year":"2018","journal-title":"Infection Genet Evol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2014.05.003","article-title":"Concurrent administration of an intranasal vaccine containing feline herpesvirus-1 (FHV-1) with a parenteral vaccine containing FHV-1 is superior to parenteral vaccination alone in an acute FHV-1 challenge model","volume":"201","author":"Reagan","year":"2014","journal-title":"Veterinary J (London England: 1997)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.2.519-523.2002","article-title":"Quantification of feline herpesvirus 1 DNA in ocular fluid samples of clinically diseased cats by real-time TaqMan PCR","volume":"40","author":"V\u00f6gtlin","year":"2002","journal-title":"J Clin Microbiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"109210","DOI":"10.1016\/j.vetmic.2021.109210","article-title":"Use of feline herpesvirus as a vaccine vector offers alternative applications for feline health","volume":"261","author":"Cottingham","year":"2021","journal-title":"Veterinary Microbiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2016.09.004","article-title":"Live attenuated pseudorabies virus developed using the CRISPR\/Cas9 system","volume":"225","author":"Tang","year":"2016","journal-title":"Virus Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"197648","DOI":"10.1016\/j.virusres.2019.197648","article-title":"Utilization of herpesviridae as recombinant viral vectors in vaccine development against animal pathogens","volume":"270","author":"Kamel","year":"2019","journal-title":"Virus Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.10.4930-4938.1990","article-title":"Recombinant feline herpesviruses expressing feline leukemia virus envelope and gag proteins","volume":"64","author":"Cole","year":"1990","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00131-4","article-title":"Recombinant feline herpesvirus type 1 expressing immunogenic proteins inducible virus neutralizing antibody against feline calicivirus in cats","volume":"14","author":"Yokoyama","year":"1996","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s007050050302","article-title":"Construction of a recombinant feline herpesvirus type 1 expressing Gag precursor protein of feline immunodeficiency virus","volume":"143","author":"Sato","year":"1998","journal-title":"Arch Virol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.03.008","article-title":"Feline herpesvirus vectored-rabies vaccine in cats: A dual protection","volume":"37","author":"Chen","year":"2019","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/vr.158.16.544","article-title":"Lethal outbreak of disease associated with feline calicivirus infection in cats","volume":"158","author":"Coyne","year":"2006","journal-title":"Veterinary Rec"},{"key":"B38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/1743-422X-8-307","article-title":"A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine","volume":"8","author":"Chen","year":"2011","journal-title":"Virol J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.790121","article-title":"Virus-like particles: revolutionary platforms for developing vaccines against emerging infectious diseases","volume":"12","author":"Tariq","year":"2021","journal-title":"Front In Microbiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2460\/javma.2004.224.61","article-title":"Duration of serologic response to three viral antigens in cats","volume":"224","author":"Mouzin","year":"2004","journal-title":"J Am Veterinary Med Assoc"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X19845702","article-title":"Antibody response to feline herpesvirus-1 vaccination in healthy adult cats","volume":"22","author":"Bergmann","year":"2020","journal-title":"J Feline Med Surg"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0186","article-title":"Raccoon poxvirus feline panleukopenia virus VP2 recombinant protects cats against FPV challenge","volume":"218","author":"Hu","year":"1996","journal-title":"Virology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00062-5","article-title":"Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine","volume":"15","author":"Hu","year":"1997","journal-title":"Vaccine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.07.020","article-title":"Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus","volume":"34","author":"Luo","year":"2016","journal-title":"Vaccine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1636514\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:41Z","timestamp":1759401221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1636514\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2025.1636514"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1636514","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1636514"}}